Illustration of adalimumab (orange) binding the cytokine tumour necrosis factor-alpha (TNF-a, blue). Adalimumab is a therapeutic monoclonal antibody used to bind excess TNF-a in the body, overproduction of which causes inflammation, swelling, and pain. It is used for the treatment of autoimmune diseases such as rheumatoid and psoriatic arthritis, Crohns disease and ulcerative colitis.
| px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TPG35116111
Source:
達志影像
Authorization Type:
RF
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
3dadalimumabalphaantitnf-aanti-tnf-aantibodyartworkautoimmunediseasebindingbiochemicalbiochemistrybiologicalbiologyboundcgicytokinedigitallygenerateddruggraybackgroundgreybackgroundhealthcarehumiraillustrationimmunesystemimmunologicalimmunologymedicalmedicationmedicinemolecularmolecularstructuremoleculemoleculesmonoclonalno-onenobodypharmaceuticpharmaceuticalpharmacologicalpharmacologyprescriptiondrugproteinsignalproteintherapythreedimensionaltreatingtreatmenttumournecrosisfactortumournecrosisfactor-alpha
3dadalimumabalphaantianti-tnf-aantibodyartworkautoimmunebackgroundbackgroundbindingbiochemicalbiochemistrybiologicalbiologyboundcgicytokinedigitallydimensionaldiseasedrugdrugfactorfactor-alphageneratedgraygreyhealthcarehumiraillustrationimmuneimmunologicalimmunologymedicalmedicationmedicinemolecularmolecularmoleculemoleculesmonoclonalnecrosisnecrosisno-onenobodypharmaceuticpharmaceuticalpharmacologicalpharmacologyprescriptionproteinproteinsignalstructuresystemtherapythreetnf-atreatingtreatmenttumourtumour
Loading